药物涂层气球为基础的治疗左主真正的分叉损伤伤
Ae-Young Her1, Tae Hyun Kim2, Eun-Seok Shin3
1Division of Cardiology, Department of Internal Medicine, Kangwon National University College of Medicine, Kangwon National University School of Medicine, Chuncheon, South Korea.
概括
药物涂层气球 (DCB) 治疗是一种安全有效的替代方案,用于未受保护的左主 (LM) 真分叉病变. 这项研究发现,基于DCB和药物释放支架 (DES) 治疗之间的2年结果相似,支持在精选患者中使用DCB.
科学领域:
- 干预心脏病学 干预心脏病学
- 血管医学 血管医学
- 生物材料在医学中的应用
背景情况:
- 有限的数据存在于药物涂层气球 (DCB) 用于左主 (LM) 真分叉病变的使用.
- 不受保护的关节病变带来了重大治疗挑战.
研究的目的:
- 评估基于DCB的策略在治疗未受保护的LM真分支病变时的安全性和有效性.
- 将基于DCB的治疗结果与传统的药物排泄支架 (DES) 方法进行比较.
主要方法:
- 对39名用DCB (单独或与DES) 治疗LM真分支病变的患者的回顾性分析.
- 与39名倾向匹配的患者进行了比较,这些患者接受了COBIS III注册表中的第二代DES治疗.
- 主要终点:在2年随访时发生的重大不良心血管事件 (MACE),包括心脏死亡,心脏病发作,支架血栓形成和目标病变再血管化.
主要成果:
- 基线特征相似,尽管DCB组有更多的静脉静脉复缩 (ISR) 病变.
- 在DCB组中,59%的患者仅接受DCB治疗;没有发生血管突然关闭.
- 基于DCB的组 (12.8%) 和仅使用DES的组 (17.9%) (p=0.861) 的2年MACE比较率.
结论:
- 基于DCB的治疗显示了可比的临床结果,仅对不受保护的LM真分支病变的DES治疗.在2年后.
- 基于DCB的治疗是一种潜在的安全和有效的替代方案,用于精心挑选的患者,并提供适当的预扩张.
- 需要进一步的研究,比如NCT04619277试验,来证实这些发现.
相关概念视频
01:24Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...